Description

Mig S Injection

For Effective First Line Therapy in Serious Infections & Nosocomial Infections

Mig S Injection is frequently employed for diagnosing and treating various conditions, notably bacterial infections and respiratory tract infections. It stands as a testament to our commitment to delivering quality pharmaceutical solutions. Third generation Cephalosporin Board Spectrum Parenteral Antibiotic with extended spectrum and fast action.

Mig S Injection Contains Cefoperazone (1000 mg); Sulbactum (500 mg)

Uses

• Lower Respiratory
• Skin & Soft Tissue
• Bacteraemia
• Cystitis
• Peritonitis / Appendicitis
• Enteritis
• Meningitis
• Pelvic Inflammatory Disease
• T.I.
• Burns
• Bone & Joint Infection
• Septicaemia

MIG-S Key Benefits

• Active against gram +, gram – organisms as well as anaerobes
• Inhibits b-lactamases produced by bacteria & protects cefoperazone
• Dual route of excretion (bile & urine) can be administered in usual dose to patients with renal or mild to moderate hepatic impairment
• Convenient B.I.D. Dosing
• Excellent clinical efficacy 95.3% in non-neutropenic patients
• Good toleration